FDA Approved: ANTI-DIARRHEAL — Supplemental Application (CHAIN DRUG MARKETING ASSOCIATION INC.)

View source ↗

Summary

FDA approves a supplemental application for ANTI-DIARRHEAL containing loperamide hydrochloride. The applicant is Chain Drug Marketing Association Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea

Drugs mentioned

• ANTI DIARRHEAL (LOPERAMIDE HYDROCHLORIDE)

Snippet

SUPPL AP for ANTI-DIARRHEAL (LOPERAMIDE HYDROCHLORIDE)